Ikris Pharma
About Us Named Patient Program
Contact Us
Entyvio

Sourced directly from the authorized manufacturer network to ensure authenticity and quality.

You can also access detailed information by clicking Login in the website header.

Entyvio

Supplied with complete CDSCO-approved import and customs documentation, including Form 12A & 12B, CDEC, GST Bill of Entry, Commercial Invoice, and Packing List.

Medicine Name: Entyvio
Generic Name (API): Vedolizumab
Dosage Form & Strength: 108 mg
Route: Subcutaneous injection (or IV infusion for the initial induction formulation)
Drug Class: Integrin receptor antagonist (gut-selective biologic)

Manufacturer / Innovator:

Germany

Regulatory Approval:

  • US FDA
Family enjoying life with Named Patient Program access

Your Trustedworthy Partner For Named Patient Program

  • your trusted partner for named patient program

    Over a decade of trusted expertise in Named Patient Access to innovative and life-saving medicines.

  • 100% CDSCO-compliant processes ensuring safe, ethical, and responsible medicine access.

    100% CDSCO-compliant processes ensuring safe, ethical, and responsible medicine access.

  • Medicines sourced from authorized manufacturers with full batch traceability

    Medicines sourced from authorized manufacturers with full batch traceability.

  • EU-GDP Compliant Warehousing for secure, quality-controlled global distribution.

    EU-GDP compliant warehousing for secure, quality-controlled global distribution.

  • Temperature-Controlled Logistics for Safe and Timely Delivery

    Temperature-controlled logistics ensuring safe, reliable, and timely medicine delivery.

GDP Compliant
Licensed Wholesale distributor

What Is Entyvio Used For?

Entyvio (vedolizumab) is a gut-selective biologic that blocks integrin receptors to reduce inflammation in the digestive tract. It is indicated for:

  • Moderately to severely active ulcerative colitis in adults
  • Moderately to severely active Crohn's disease in adults

Entyvio is a prescription medicine and must be used under the supervision of a qualified gastroenterologist.

Recommended Dosage

  • Initial doses given as an IV infusion at weeks 0, 2, and 6
  • Maintenance therapy can continue as IV infusion every 8 weeks, or switch to the 108 mg subcutaneous pen every 2 weeks starting at week 6, in place of the next scheduled IV dose

This information is not a treatment plan. For personalized medical advice, consult your doctor and refer to the full prescribing information.

Entyvio Warnings and Precautions

  • Infusion and injection site reactions: Hypersensitivity reactions, including anaphylaxis, can occur.
  • Infections: Entyvio may increase the risk of infections; patients should be screened for tuberculosis before starting treatment.
  • Progressive multifocal leukoencephalopathy (PML): A rare but serious brain infection has been reported with drugs in this class; patients should be monitored for new neurological symptoms.
  • Liver injury: Liver function should be monitored during treatment.

How to Access Entyvio in India: A 6-Step Process

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant, cold-chain conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation & Availability

What documents are required to import Entyvio to India?

Entyvio (vedolizumab) injection may be imported in the patient's name only, by patients or government hospitals, in line with India's import regulations for unapproved medicines. The following documentation is required:

  • A valid prescription from a qualified gastroenterologist
  • The patient's diagnostic reports confirming ulcerative colitis or Crohn's disease
  • Patient ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription from the doctor and, if applicable, an import permit.

Is Entyvio available in India?

Entyvio (vedolizumab injection) is a prescription medicine that legally requires a doctor's prescription to be dispensed. As of current publicly available information, Entyvio is not commercially marketed in India.

However, patients in India can legally access Entyvio through the Named Patient Program (NPP) — an import provision that allows patients to receive medicines approved in other countries but not yet marketed in India, under a doctor's prescription and proper regulatory documentation.

Entyvio received US FDA approval in 2014 for ulcerative colitis and Crohn's disease, ensuring full transparency throughout the process.

Entyvio can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others.

For patients with Crohn's disease or ulcerative colitis, NPP also facilitates access to Skyrizi and Humira, other biologic options, based on the treating gastroenterologist's assessment.

Sourcing & Delivery of Entyvio

Entyvio is sourced directly from authorized channels in the country of origin and shipped to India under GDP-compliant, cold-chain logistics to preserve product integrity from dispatch to delivery.

  • Cold-chain shipping maintained at 2°C to 8°C throughout transit
  • Real-time shipment tracking and delivery updates
  • Delivery coordinated directly with the patient, family, or treating hospital

Availability of Entyvio Across Major Cities in India

Named Patient Program supports access to Entyvio for patients with ulcerative colitis and Crohn's disease across major cities in India, coordinating documentation, sourcing, and delivery with treating gastroenterologists.

Mumbai

Patients in Mumbai can access Entyvio through NPP with support from treating gastroenterologists.

Delhi

In Delhi, NPP coordinates with hospitals and specialty gastroenterology clinics to facilitate timely access to Entyvio.

Bangalore

Bangalore's gastroenterology centers work with NPP to support patients requiring Entyvio.

Chennai

Patients in Chennai can access Entyvio through NPP, with coordination between treating doctors and the program's regulatory and logistics team.

Hyderabad

Hyderabad's gastroenterology centers support diagnosis and access coordination for Entyvio through NPP.

Kolkata

NPP facilitates access to Entyvio for patients in Kolkata under the guidance of treating specialists.

Pune

Patients in Pune can access Entyvio through NPP with prescription-based coordination and cold-chain delivery support.

Ahmedabad

NPP supports access to Entyvio for patients in Ahmedabad, working directly with treating specialists.

Kochi

Patients in Kochi and across Kerala can access Entyvio through NPP's regulated import pathway.

Chandigarh

NPP coordinates access to Entyvio for patients in Chandigarh and the surrounding region.

Jaipur

Patients in Jaipur can access Entyvio through NPP with support from treating gastroenterologists.

Lucknow

NPP facilitates access to Entyvio for patients in Lucknow and across Uttar Pradesh.

Bhubaneswar

Patients in Bhubaneswar can access Entyvio through NPP's coordinated import and delivery process.

Guwahati

NPP supports access to Entyvio for patients in Guwahati and across the Northeast region.

NPP also supports access for patients in other Indian cities not listed above — contact the team to check availability and timelines for your location.

Written By:

Written By: Nitin Goswami, Senior Medical Content Writer
Last Updated: 09 September 2026
Sources: FDA • CDSCO

Medically Reviewed By:

Medically Reviewed By: Shilpi Banerjee, Registered Pharmacist (M.Pharm)
Last Updated: 09 September 2026

TRUSTED BY HEALTHCARE PROFESSIONALS & HOSPITALS

Need Help
Accessing Medicines?

Our specialists are here to guide you through every step of the medicine access process.

Let's us help!

Send us a message

Read how to access medicines

Read More arrow icon

Frequently Asked
Questions

Read More